$BOSQF,...YIELD GROWTH Announces Patent Pending

New Post Public Reply Private Reply Replies (0) Message Board
nlightn
70
$BOSQF,...YIELD GROWTH Announces Patent Pending Manufacturing Technique Yields High Concentration of Terpenes in Hemp Root Oil
Tue July 23, 2019

VANCOUVER, BC / ACCESSWIRE / July 23, 2019 / The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (FSE:YG3) is pleased to announce a breakthrough in its ongoing research and development of the cannabis sativa (hemp) root, as research data has indicated high concentrations of therapeutic compounds. With its patent pending technology, Yield Growth has innovatively developed this hemp root oil process by sequestering the target compounds more efficiently, resulting in higher yields needed for increasingly larger production orders. To satisfy the burgeoning market demand for high-quality hemp-based products, Yield Growth has developed a scalable and cost effective production model incorporating this breakthrough in hemp root oil manufacturing.

8f7f5ee3-3daf-4965-a94b-a340e20b4c28.png

Research data indicates that hemp roots oil used in Urban Juve and Wright & Well products contains high concentrations of therapeutic compounds

While much research has been undertaken to understand the potential health benefits for other parts of the cannabis plant, Yield Growth’s research and development to date is focused on the plant’s root. According to a review paper written by Dr. Ethan Russo, medical and therapeutic use of the cannabis root throughout history includes uses to treat fever, inflammation, arthritis, joint pain, burns and tumors.

Yield Growth Corp subsidiary Wright & Well uses hemp root oil infused with CBD and THC in its products, intended for pain relief. These Infused products will create an entourage effect for greater therapeutic benefit when combined with terpenes and other compounds in the hemp root.

“With the hemp plant supplying such a dynamic range of health benefits for the above ground portion of the plant, why should we expect anything less from the roots, the very foundation of the plant?” says Bhavna Solecki, Director of Product Development. By introducing hemp root oil to the new and ever-expanding market, Yield Growth is staking its claim. Testimonials and customer feedback continue to confirm the quality and effectiveness of the company’s products, with many reporting excellent results in skin health from using the Urban Juve line of products, which incorporate hemp root oil as a key ingredient.

About The Yield Growth Corp.

The Yield Growth Corp. develops, manufactures and distributes cannabis and hemp infused product brands Urban Juve and Wright & Well and has a catalogue of over 200 wellness and beauty formulas. It intends to disrupt the international wellness market, which is a $4.2 trillion global economy, according to the Global Wellness Institute, by connecting ancient healing with modern science and technology. Its management team has deep experience with global brands including Johnson & Johnson (JNJ), Procter & Gamble, M·A·C Cosmetics, Skechers, Best Buy, Aritzia (ATZAF), Coca-Cola and Pepsi Corporation. Yield Growth serves mainstream luxury consumers who seek sophisticated wellness products. Its flagship consumer brand, Urban Juve, has proprietary, patent-pending extraction technology and has 12 patents pending. Yield Growth is building sophisticated international distribution channels and has multiple revenue streams including services, licensing and product sales.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop.

Investor Relations Contacts:

Penny Green, President & CEO
Kristina Pillon, Investor Relations
invest@yieldgrowth.com
1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677

https://seekingalpha.com/pr/17579132-yield-gr...centration
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff McLean Takes the Helm as ghSMART's New CEO

Updated Category News Views 620

Jeff McLean Takes the Helm as ghSMART's New CEO G.H. Smart & Company, LLC, the leading firm in leadership advisory, proudly announces the appointment of Jeff McLean as the Chief Executive Officer. McLean, who has been serving as President of ghSMART for three years, will now guide the firm towards its next exciting phase of growth and innovation. Achievements Under...

Continue Reading
Growth Forecast for Hot Dog and Sausage Market to 2032

Updated Category News Views 51

Introduction to the Hot Dog and Sausage Market The global market for hot dogs and sausages is witnessing a remarkable upward trajectory, with projections estimating it will reach USD 112.41 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 3.50%. The factors contributing to this expansion are numerous, including shifting consumer...

Continue Reading
Exro Technologies Adjusts Leadership with New CEO Plans

Updated Category News Views 337

Exro Technologies Announces Leadership Changes Exro Technologies Inc. has made a significant announcement regarding its leadership structure. Following the resignation of Sue Ozdemir from her role as Chief Executive Officer, the company has initiated steps to ensure a seamless transition and continuity in leadership. New Chief Restructuring Officer Appointed Introduction...

Continue Reading
Hillenbrand Increases Quarterly Dividend to $0.225 Per Share

Updated Category News Views 208

Hillenbrand's Exciting Dividend Announcement The board of directors of Hillenbrand, Inc. (NYSE: HI) has proudly announced a regular cash dividend of $0.225 per share on its common stock. This announcement signifies an annual increase of $0.01, bringing the total dividend rate to $0.90 per share for fiscal 2025. Such a commitment underlines Hillenbrand's dedication to...

Continue Reading
Trump's World Liberty Financial Token Sale Raises $220 Million

Updated Category News Views 113

Trump's World Liberty Financial Token Sale Demonstrates Huge Demand The World Liberty Financial project, closely associated with Donald Trump, made headlines recently as its token sale reached an impressive $220 million in just the first hour. Despite facing multiple outages on its website, the initiative showcased remarkable demand and interest. Details of the Token Sale...

Continue Reading